The failing heart and the hemodynamic response to vasodilator therapy

Clinical Cardiology

Volumn 26, Issue 6, 2003, Pages 257-258

  Mills, Roger M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDRALAZINE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; NESIRITIDE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

CLINICAL TRIAL; DRUG CHOICE; EDITORIAL; EXERCISE TOLERANCE; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT ATRIUM PRESSURE; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMIC MONITORING; HUMAN; INOTROPISM; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; VASODILATATION;

EID: 0037532810     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4950260603     Document Type: Editorial

References (12)

1. Anand IS, Florea VC, Fisher L: Surrogate end points in heart failure. J Am Coll Cardiol 2002;39:1414-1421
2. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN: Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HEFT VA Cooperative Studies Group. Circulation 1993;87(6 suppl):VI17-123
3. Poole-Wilson PA: Treatment of acute heart failure: Out with the old, in with the new. J Am Med Assoc 2002;287:1578-1580
4. Stevenson LW, Bellil D, Grover-McKay M, Brunken RC, Schwaiger M, Tillisch JH, Schelbert HR: Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:654-658
5. Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stevenson LW: Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002;39:1623-1629
6. Hobbs RE, Miller LW, Bott-Silverman C, James KB, Rincon G, Grossbard EB: Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996;78:896-901
7. Mills RM, LeJemtel TH, Horton DP, Liang C, Lang R, Silver MA: Sustained hemodynamic effects of an infusion of nesiritide (human B-type natriuretic peptide) in heart failure: A randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 1999;34:155-162
8. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Jefferson AD: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated heart failure. N Engl J Med 2000;343:246-253
9. Publication Committee for the VMAC Investigators: Intravenous nesiritide vs. nitroglycerin for treatment of decompensated heart failure: A randomized controlled trial. J Am Med Assoc 2002;287:1531-1540
10. Weiland DS, Konstam MA, Salem DN, Martin TT, Cohen SR, Zile MR, Das D: Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:1046-1050
11. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M: Short-termintravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. J Am Med Assoc 2002;287:1541-1547
12. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P: Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987;57:17-22